Molecular detection of human papillomavirus in 594 uterine cervix samples from Moroccan women (147 biopsies and 447 swabs)

Journal of Clinical Virology

Volumn 27, Issue 3, 2003, Pages 286-295

  Amrani, Mariam ^a   Lalaoui, Khalid ^b   El Mzibri, Mohammed ^b   Lazo, Pedro ^c   Belabbas, Mohamed Alaoui ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Morocco)

^b CENTRE NATIONAL DE L ENERGIE DES SCIENCES TECHNIQUES NUCLEAIRES   (Morocco)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Human papillomavirus; Molecular HPV testing; Pathology; Uterine cervix

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOLOGY; DNA EXTRACTION; DNA ISOLATION; FEMALE; GYNECOLOGY; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MOROCCO; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVICITIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; VIRUS INFECTION; VIRUS STRAIN; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; MOROCCO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0038149988     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(02)00227-5     Document Type: Article

References (31)

1. Amrani M. Les lésions condylomateuses du col utérin: à propos de 86 cas avec revue de la littérature. Medical Doctorate Thesis No. 50, Mohamed V University, Faculty of Medicine and Pharmacy, Rabat, Morocco, 1985. p. 136.
2. Bauer H.M., Ting Y., Greer C.E., Chambers J.C., Tashiro J.C., Chimera C.L., et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA. 256:1991;472-477.
3. Bosch F.X., Manos M.M., Muñoz N., Sherman M., Jansen A.M., Peto J., et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:1995;796-802.
4. Chaouki N., Bosch F.X., Muñoz N., Meijer C.J.L.M., El Gueddari B., El Ghazi A., et al. The viral origin of cervical cancer in Rabat, Morocco. Int. J. Cancer. 75:1998;546-554.
5. Coste-Burel M., Besse B., Moreau A., Imbert B.M., Mensier A., Sagot P., et al. Detection of human papillomavirus in squamous intraepithelial lesions by consensus and type-specific polymerase chain reaction. Eur. J. Obstet. Gynecol. Reprod. Biol. 52:1993;193-200.
6. Cuzick J. Cost issues in introducing HPV testing into a cervical screening programme. In: HPV summit: new approaches in the detection and elimination of cervical cancer. February 8-10, 1999. Chamonix, France. p. 24-25.
7. Franco E., Ferenczy A. Assessing gains in diagnostic utility when human papillomavirus testing is used as an adjunct to Papanicolaou smear in the triage of women with cervical cytologic abnormalities. Am. J. Obstet. Gynecol. 181:1999;382-386.
8. Fernández-Contreras M.E., Sarriá C., Nieto S., Lazo P.A. Amplification of human genomic sequences by human papillomavirus universal consensus primers. J. Virol. Meth. 87:2000;171-175.
9. Gòrska-Flipot I., Nolet S., Boivin Y., Lambert B., Gaboury L. Approche moléculaire du diagnostic des lésions précancéreuses du col utérin. Ann. Biochim. Clin. Qué. 35:1996;66-70.
10. Greer C.E., Wheeler C.M., Manos M.M. PCR amplification from paraffin-embedded tissues: sample preparation and the effects of fixation. PCR Meth. Appl. 3:1994;113-122.
11. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70.
12. Husnjak K., Grce M., Magdic L., Pavelic K. Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens. J. Virol. Meth. 88:2000;125-134.
13. IARC. International Agency on Research on Cancer. 1995. Monograph on cancer, human papillomavirus. Vol. 64. World Health Organisation.
14. Jacobs M.V., Snijders P.J., Voorhorst F.J., Dillner J., Forslund O., Johansson B., et al. Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison. J. Clin. Pathol. 52:1999;498-503.
15. Jin X.W., Cash J., Kennedy A.W. Human papillomavirus typing and the reduction of cervical cancer risk. Cleve Clin. J. Med. 66:1999;533-539.
16. Josefsson A.M., Magnusson P.K., Ylitalo N., Sorensen P., Qwarforth-Tubbin P., Andersen P.K., et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet. 355:2000;2189-2193.
17. Lazo P.A. Papillomavirus integration: prognostic marker in cervical cancer. Am. J. Obstet. Gynecol. 176:1997;1121-1122.
18. Lazo P.A. The molecular genetics of cervical carcinoma. Br. J. Cancer. 80:1999;2008-2018.
19. Lorincz A.T., Reid R., Jenson A.B., Greenberg M.D., Lancaster W., Kurman R.J. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol. 79:1992;328-337.
20. Lousuebsakul V., Knutsen S.M., Gram I.T., Akin M.R. Clinical impact of atypical squamous cells of undetermined significance. A cytohistologic comparison. Acta Cytol. 44:2000;23-30.
21. Marsou Z. Traitement radiochirurgical des cancers du col utérin à un stade précoce (stades I et II proximaux) 1985-1994. Medical Doctorate Thesis No. 218, Mohammed V University, Faculty of Medicine and Pharmacy, Rabat, Morocco, 1997. p. 164.
22. Matthews C.P., Shera K.A., McDougall J.K. Genomic changes and HPV type in cervical carcinoma. Proc. Soc. Exp. Biol. Med. 223:2000;316-321.
23. McGlennen R.C. Human papillomavirus oncogenesis. Clin. Lab. Med. 20:2000;383-406.
24. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: a laboratory manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
25. Vassilakos P., de Marvel F., Campana A. Human papillomavirus (HPV) DNA assay as an adjunct to the liquid-based Pap test in the diagnostic triage of women with an abnormal Pap smear. Int. J. Gynecol. Obstet. 61:1998;45-50.
26. Vassilakos P. HPV: the mechanics of implementation. HPV summit: new approaches in the detection and elimination of cervical cancer. February 8-10, 1999. Chamonix, France. p. 8-9.
27. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:1999;12-19.
28. Wallin K., Wiklund F., Angstrom T., Bergman F., Stendahl U., Wadell G., et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical carcinoma. N. Engl. J. Med. 341:1999;1633-1638.
29. Weintraub J. Expérience des téchnologies nouvelles dans le contexte d'exercice de la suisse et conclusions. Ann. Pathol. 19:1999;96-98.
30. Woodhouse S.L., Stastny J.F., Styer P.E., Kennedy M., Praestgaard A.H., Davey D.D. Interobserver variability in subclassification of squamous intraepithelial lesions: results of the college of American pathologists interlaboratory comparison program in cervicovaginal cytology. Arch. Pathol. Lab. Med. 23:1999;1079-1084.
31. Zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 92:2000;690-698.